Published in Clin Pharm on February 01, 1991
Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin Pharmacol Ther (2008) 1.30
The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med (2005) 1.24
Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med (2012) 1.16
Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects. Clin Pharmacokinet (1992) 0.76
Drug interactions with clinafloxacin. Antimicrob Agents Chemother (2001) 0.76
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
Are endoscopic measurements of colonic polyps reliable? Am J Gastroenterol (1993) 2.64
Dislocation of the elbow with fracture of the radial head and distal radius. JAMA (1967) 2.20
Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc (1991) 2.17
Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling. Am J Clin Pathol (1990) 2.10
Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol (1997) 1.81
Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest (1981) 1.79
Non-erosive reflux disease (NERD)--acid reflux and symptom patterns. Aliment Pharmacol Ther (2003) 1.69
Recall strategies and memory for health-care visits. Milbank Q (1990) 1.62
Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology (1989) 1.61
Flow cytometry in Barrett's esophagus. What have we learned so far? Dig Dis Sci (1991) 1.48
Effectiveness of India ink as a long-term colonic mucosal marker. Am J Gastroenterol (1992) 1.45
Antioxidants and the prevention of coronary heart disease. Arch Intern Med (1995) 1.41
A procedure for the estimation of microgram quantities of triton X-100. Anal Biochem (1973) 1.40
The difference in colon polyp size before and after removal. Gastrointest Endosc (1996) 1.40
Word-processing training and retraining: effects of adult age, experience, and interface. Psychol Aging (2001) 1.36
Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut (2001) 1.34
Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody. Virus Res (1996) 1.27
Intestinal metaplasia of the stomach: identification by a selective mucosal staining technique. Gastrointest Endosc (1993) 1.26
Triton X-100-4 M urea as an extraction medium for membrane proteins. I. Purification of chloroplast cytochrome b559. Biochemistry (1974) 1.20
Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc (1996) 1.16
Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay. J Clin Microbiol (1996) 1.14
ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J Natl Cancer Inst (1986) 1.13
Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci (1990) 1.12
Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci (1993) 1.08
Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother (1998) 1.08
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg (1996) 1.05
Lack of spontaneous regression of tubular adenomas in two years of follow-up. Am J Gastroenterol (1997) 1.03
Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol (1998) 1.01
Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. Resuscitation (1990) 0.99
Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev (1993) 0.98
Amniotic fluid embolism. A review of the syndrome with a report of 4 cases. Obstet Gynecol (1965) 0.98
Humeral neck fracture with inferior subluxation of the shoulder joint. JAMA (1966) 0.96
Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature. Neurosurgery (1986) 0.96
Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. Cancer Epidemiol Biomarkers Prev (1993) 0.94
Current trends in the pharmacotherapy for peptic ulcer disease. Arch Intern Med (1992) 0.92
Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc (1999) 0.92
Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor. Aliment Pharmacol Ther (2000) 0.91
The myelodysplastic syndromes: biology and implications for management. J Clin Oncol (1990) 0.89
The use of wire mesh in total hip replacement surgery. Clin Orthop Relat Res (1975) 0.89
Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease. Ann Emerg Med (1984) 0.89
Review article: Barrett's oesophagus--cancer risk, biology and therapeutic management. Aliment Pharmacol Ther (1993) 0.88
Auto-immune progesterone eczema. An endogenous progesterone hypersensitivity. Arch Dermatol (1969) 0.87
A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int J Cancer (1995) 0.86
Severely comminuted intertrochanteric hip fracture. JAMA (1967) 0.85
Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (1994) 0.84
Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. Gastrointest Endosc (2001) 0.84
Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth. In Vitro Cell Dev Biol (1987) 0.84
Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery. Am J Gastroenterol (1988) 0.83
Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (1993) 0.83
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Dig Dis Sci (1997) 0.83
Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Ageing (2000) 0.83
Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication. J Clin Gastroenterol (2001) 0.82
Triton X-100-4 M urea as an extraction medium for membrane proteins. II. Molecular properties of pure cytochrome b559: a lipoprotein containing small polypeptide chains and a limited lipid composition. Biochemistry (1974) 0.82
The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer (1991) 0.82
Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium. Clin Pharm (1987) 0.81
Cigarette smoking and ethane exhalation in humans. Am J Respir Crit Care Med (1995) 0.81
Radial neck fracture in a child. JAMA (1967) 0.81
Discrepancy in the assessment of tumor response in patients with pancreatic cancer: WHO versus RECIST criteria. J BUON (2008) 0.80
Pathological fracture of the femoral neck. JAMA (1968) 0.80
Management of high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol (1989) 0.80
Purification of chloroplast cytochrome b 559 . Biochem Biophys Res Commun (1971) 0.80
Bilateral shoulder fracture-dislocations. JAMA (1966) 0.80
Effect of vitamin E on exhaled ethane in cigarette smokers. Chest (1999) 0.80
Gas gangrene complicating fracture of the tibia. JAMA (1969) 0.80
Efficacy of danazol in pure red cell aplasia. Am J Hematol (1986) 0.80
Effect of danazol on coagulation parameters and bleeding in hemophilia. JAMA (1985) 0.79
Potential interaction between warfarin and fluvastatin. Ann Pharmacother (1996) 0.79
Managing malignant pericardial effusion. West J Med (1989) 0.79
Pathologic fracture of the proximal femur. JAMA (1967) 0.79
Labelling deficiencies and communication problems leading to medication misuse in the elderly. Drugs Aging (1994) 0.79
Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc Natl Acad Sci U S A (1995) 0.78
Appropriateness of long-term cimetidine prescribing. Drug Intell Clin Pharm (1984) 0.78
Management of myelodysplastic syndromes. Am J Med (1986) 0.78
Epiphysial fracture of the proximal humerus. JAMA (1969) 0.78
Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients. Cancer Chemother Pharmacol (1989) 0.77
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study. Invest New Drugs (1991) 0.77
Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost? Dig Dis Sci (1994) 0.77
Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett's esophagus. Dis Esophagus (2006) 0.76
Influence of beta-carotene on immune functions. Ann N Y Acad Sci (1993) 0.76
Current trends in the pharmacotherapy for gastroesophageal reflux disease. Arch Intern Med (1992) 0.76
Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. Scand J Haematol (1985) 0.76
Biological monitoring of cancer chemoprevention. J Surg Oncol (1992) 0.76
A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 0.76
Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med (1989) 0.76
Metoclopramide in vincristine-induced ileus. Cancer Treat Rep (1985) 0.76
Precancerous lesions and biologic markers in esophageal cancer. Cancer Detect Prev (1991) 0.76
A collaborative end-of-life care curriculum. Am J Hosp Palliat Care (2001) 0.75
Exhaled ethane and antioxidant vitamin supplements in active smokers. Chest (1996) 0.75
Endoscopic polypectomy reduces mortality from colorectal cancer. Arch Intern Med (1995) 0.75
Aspirin in the prevention of colorectal cancer. Ann Intern Med (1994) 0.75
Pericardial effusion in association with giant cell arteritis. West J Med (1981) 0.75
Acute promyelocytic leukemia. West J Med (1987) 0.75
Transforming growth factor-beta1: a useful tumor marker in patients with colorectal carcinoma? Cancer (1999) 0.75
Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984). Recent Results Cancer Res (1984) 0.75
Femoral-shaft fracture below hip prosthesis. JAMA (1965) 0.75
Internal derangement of the knee. JAMA (1965) 0.75